These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 14522910)

  • 21. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
    Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
    Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta1 regulates cell growth and causes downregulation of SMemb/non-muscle myosin heavy chain B mRNA in human prostate stromal cells.
    Obara K; Bilim V; Suzuki K; Kobayashi K; Hara N; Kasahara T; Nishiyama T; Takahashi K
    Scand J Urol Nephrol; 2005; 39(5):366-71. PubMed ID: 16257837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis.
    Santamaria-Martínez A; Barquinero J; Barbosa-Desongles A; Hurtado A; Pinós T; Seoane J; Poupon MF; Morote J; Reventós J; Munell F
    Exp Cell Res; 2009 Oct; 315(17):3004-13. PubMed ID: 19447103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
    Vosseler S; Mirancea N; Bohlen P; Mueller MM; Fusenig NE
    Cancer Res; 2005 Feb; 65(4):1294-305. PubMed ID: 15735015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
    Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
    Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
    Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
    Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.
    Collado B; Carmena MJ; Clemente C; Prieto JC; Bajo AM
    Peptides; 2007 Sep; 28(9):1896-901. PubMed ID: 17544169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
    Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
    Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
    Bandyopadhyay A; Wang L; López-Casillas F; Mendoza V; Yeh IT; Sun L
    Prostate; 2005 Apr; 63(1):81-90. PubMed ID: 15468171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
    Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
    Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S; Dong Z
    Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.
    Sakko AJ; Ricciardelli C; Mayne K; Tilley WD; Lebaron RG; Horsfall DJ
    Cancer Res; 2001 Feb; 61(3):926-30. PubMed ID: 11221884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.